TriSalus Operating Cycle from 2010 to 2026

TLSI Stock   5.26  0.27  4.88%   
TriSalus Life's Operating Cycle is decreasing with slightly volatile movements from year to year. Operating Cycle is predicted to flatten to 317.54. For the period between 2010 and 2026, TriSalus Life, Operating Cycle quarterly trend regression had mean deviation of  36.48 and range of 171. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
380.88
Current Value
317.54
Quarterly Volatility
52.17501118
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TriSalus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TriSalus Life's main balance sheet or income statement drivers, such as Tax Provision of 7.4 K, Interest Income of 279.1 K or Interest Expense of 3.7 M, as well as many indicators such as Price To Sales Ratio of 4.93, Dividend Yield of 0.0 or Days Sales Outstanding of 47.59. TriSalus financial statements analysis is a perfect complement when working with TriSalus Life Valuation or Volatility modules.
  
Build AI portfolio with TriSalus Stock
Check out the analysis of TriSalus Life Correlation against competitors.

Latest TriSalus Life's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of TriSalus Life Sciences over the last few years. It is TriSalus Life's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

TriSalus Operating Cycle Regression Statistics

Arithmetic Mean428.40
Geometric Mean424.82
Coefficient Of Variation12.18
Mean Deviation36.48
Median454.25
Standard Deviation52.18
Sample Variance2,722
Range171
R-Value(0.62)
Mean Square Error1,787
R-Squared0.38
Significance0.01
Slope(6.41)
Total Sum of Squares43,556

TriSalus Operating Cycle History

2026 317.54
2025 380.88
2024 423.2
2023 426.67
2022 283.62

About TriSalus Life Financial Statements

Investors use fundamental indicators, such as TriSalus Life's Operating Cycle, to determine how well the company is positioned to perform in the future. Although TriSalus Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 380.88  317.54 

Currently Active Assets on Macroaxis

When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out the analysis of TriSalus Life Correlation against competitors.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.12)
Revenue Per Share
1.217
Quarterly Revenue Growth
0.574
Return On Assets
(0.61)
Return On Equity
(4.96)
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.